drugset / Trial / NCT06221059
Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study was to evaluate the efficacy of HRS-1780 tablets or Henagliflozin Proline tablets in patients with chronic kidney disease by evaluating UACR change from baseline to Week 13
Timeline
- Start
- 2024-03-02
- Primary completion
- 2025-03-05
- Completion
- 2025-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-1780 | Small molecule | — | — |
| Subject | Henagliflozin Proline | Unknown | — | — |